Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Director/PDMR Shareholding - Replacement

8 Mar 2017 18:21

RNS Number : 9264Y
De La Rue PLC
08 March 2017
 

De La Rue plc

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

8 March 2017

De La Rue plc (the "Company") has been advised today by Equiom (Guernsey) Limited as Trustee of the De La Rue Employee Share Ownership Trust that on 7 March 2017, the Trustees made a market share purchase of 21,293 ordinary shares of 44 152/175p  in the capital of the Company, and on behalf of the Company, at a price of 625.5p per share, to satisfy the vesting of an award made to Martin Sutherland, Chief Executive Officer (for nil consideration), on 26 November 2014 and the subsequent sale of 10,028 of those shares at a price of 625.5p per share to cover tax and social security. The remainder of the shares (11,265) are being retained.

The notification below is provided in accordance with the requirements of the EU Market Abuse Regulations.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Martin Sutherland

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer (and PDMR)

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

De La Rue plc

b)

 

LEI

 

213800DH741LZWIJXP78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 44 152/175p

 

 

GB00B3DGH821

b)

 

Nature of the transaction

 

 

(i) Vesting of 21,293 ordinary shares of an award made in November 2014; and (ii) the subsequent sale of sufficient shares to cover tax and social security. The remainder of the shares (11,265) are being retained.

c)

 

Price(s) and volume(s)

 

 

 

Transaction

Price(s)

 

Volume(s)

Total

Vesting

 

Nil

21,293

Nil

Sale for tax

625.5p

10,028

£62,725.14

 

 

d)

 

Aggregated information

 

 

Transaction

Price(s)

 

Volume(s)

Total

Vesting

 

Nil

21,293

Nil

Sale for tax

625.5p

10,028

£62,725.14

 

 

e)

 

Date of the transaction

 

2017-03-07 (GMT)

f)

 

Place of the transaction

 

(i) Vesting: Outside a trading venue

(ii) Sale: London Stock Exchange (XLON)

 

Ed Peppiatt, Company Secretary

Contact Number: 01256 605343

8 March 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSAFAAFWSEFD
Date   Source Headline
11th Aug 20237:00 amRNSDirectorate Change
4th Aug 20237:00 amRNSDirectorate Change
3rd Aug 20239:21 amRNSAppointment of Joint Broker
2nd Aug 20233:26 pmRNSDirector/PDMR Shareholding
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 20231:44 pmRNSDirector/PDMR Shareholding
24th Jul 20233:04 pmRNSHolding(s) in Company
20th Jul 20234:03 pmRNSHolding(s) in Company
20th Jul 202312:17 pmRNSAnnual Financial Report
19th Jul 20231:01 pmRNSHolding(s) in Company
11th Jul 202310:28 amRNSDirector/PDMR Shareholding
4th Jul 202312:59 pmRNSHolding(s) in Company
3rd Jul 20235:44 pmRNSHolding(s) in Company
3rd Jul 202312:12 pmRNSBlock listing Interim Review
3rd Jul 202312:09 pmRNSTotal Voting Rights
30th Jun 20231:40 pmRNSHolding(s) in Company
30th Jun 20231:35 pmRNSHolding(s) in Company
30th Jun 202310:11 amRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSFY23 full year results
28th Jun 20235:25 pmRNSHolding(s) in Company
28th Jun 20231:50 pmRNSHolding(s) in Company
27th Jun 20231:57 pmRNSHolding(s) in Company
27th Jun 20231:54 pmRNSHolding(s) in Company
26th Jun 20237:00 amRNSDirectorate Change
22nd Jun 20234:43 pmRNSHolding(s) in Company
21st Jun 20233:29 pmRNSHolding(s) in Company
19th Jun 20237:00 amRNSDirectorate Change
12th Jun 20237:00 amRNSDirectorate Change
1st Jun 202310:36 amRNSTotal Voting Rights
23rd May 20234:33 pmRNSHolding(s) in Company
18th May 20237:00 amRNSAppointment of Chairman
9th May 20237:00 amRNSNotice of Results
2nd May 20237:00 amRNSFurther re recruitment of Chairman
18th Apr 20232:52 pmRNSWithdrawal of General Meeting requisition
14th Apr 20234:19 pmRNSResignation of Chairman and accelerated search
12th Apr 20237:00 amRNSTrading update
6th Apr 20237:00 amRNSFurther re appointment of CFO
3rd Apr 202311:41 amRNSTotal Voting Rights
31st Mar 20237:00 amRNSNotice of GM
30th Mar 202312:24 pmRNSHolding(s) in Company
24th Mar 202310:46 amRNSHolding(s) in Company
23rd Mar 202310:38 amRNSHolding(s) in Company
17th Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20232:00 pmRNSHolding(s) in Company
22nd Feb 20231:03 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSDirectorate Change
20th Jan 20237:00 amRNSStatement re Kenya and India
6th Jan 20232:35 pmRNSHolding(s) in Company
3rd Jan 202312:14 pmRNSBlock listing Interim Review
2nd Dec 20224:42 pmRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.